Peachtree Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$863K Buy
20,839
+4,085
+24% +$170K 0.67% 33
2018
Q3
$701K Buy
16,754
+632
+4% +$24.3K 0.48% 38
2018
Q2
$555K Buy
16,122
+1,618
+11% +$55.3K 0.4% 48
2018
Q1
$488K Buy
14,504
+2,993
+26% +$103K 0.37% 49
2017
Q4
$396K Buy
11,511
+3,136
+37% +$107K 0.3% 65
2017
Q3
$284K Sell
8,375
-738
-8% -$23.7K 0.24% 71
2017
Q2
$290K Buy
9,113
+1,191
+15% +$37.6K 0.25% 74
2017
Q1
$257K Buy
7,922
+106
+1% +$3.34K 0.24% 77
2016
Q4
$241K Hold
7,816
0.24% 85
2016
Q3
$251K Hold
7,816
0.25% 78
2016
Q2
$261K Hold
7,816
0.27% 81
2016
Q1
$220K Hold
7,816
0.22% 85
2015
Q4
$239K Buy
7,816
+910
+13% +$28.6K 0.25% 85
2015
Q3
$206K Sell
6,906
-651
-9% -$20.9K 0.21% 100
2015
Q2
$240K Buy
7,557
+7
+0.1% +$228 0.18% 109
2015
Q1
$249K Sell
7,550
-1,730
-19% -$55K 0.18% 113
2014
Q4
$274K Sell
9,280
-4,768
-34% -$137K 0.18% 122
2014
Q3
$394K Buy
14,048
+1,222
+10% +$34.3K 0.26% 98
2014
Q2
$361K Sell
12,826
-43
-0.3% -$1.23K 0.24% 98
2014
Q1
$392K Sell
12,869
-356
-3% -$10.6K 0.27% 93
2013
Q4
$384K Buy
+13,225
New +$385K 0.26% 95

Other funds holding PFE

Peachtree Investment Advisors's PFE Position: Q4 2018 in Review

Peachtree Investment Advisors increased its Pfizer (PFE) stake by 24% in Q4 2018, buying an estimated $170K and bringing the position to 20,839 shares worth $863K. The position accounts for 0.67% of the portfolio, ranked #33.

Peachtree Investment Advisors first reported a position in PFE in Q4 2013 and has held it in 21 quarters since. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

  • Peachtree Investment Advisors held 20,839 shares of Pfizer worth $863K as of Q4 2018.
  • Peachtree Investment Advisors bought 4,085 Pfizer shares in Q4 2018, an estimated $170K.
  • Pfizer made up 0.67% of Peachtree Investment Advisors's portfolio in Q4 2018, its #33 holding.
  • Peachtree Investment Advisors first reported a position in Pfizer in Q4 2013 and has held it in 21 quarters since.
  • 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Peachtree Investment Advisors's 13F filing for Q4 2018, filed 14 Jan 2019.